(Total Views: 544)
Posted On: 09/08/2021 1:15:31 AM
Post# of 154858
I was incorrect. But it did get me interested in why leronlimab would still remain so effective in the face of cell to cell transfer. Leronlimab's downregulation of the PI3K/AKT pathway may inhibit glycosylation and cell adhesion.
(1)
(0)
